Curriculum Vitae-Dr. Stricker

Raphael B. Stricker, M.D.

Curriculum Vitae

Education

1961-67      Horace Mann High School, Bronx, NY.  Diploma 6/67.

1967-71      Columbia College, New York, NY.  BA 6/71

1972-75      University of Lausanne Medical School, Lausanne, Switzerland

1975-78      Columbia University College of Physicians & Surgeons, New York, NY. MD 6/78

 

 Postgraduate Training and Appointments

1978-81      Residency:  Internal Medicine, St. Luke’s-Roosevelt Hospital Center, New York, NY

1981-84     Fellowship:  Hematology/Oncology, Cancer Research Institute, University of California, San   Francisco, CA

1984-85     Postdoctoral Research Scholar, Cancer Research Institute, University of California, San Francisco, CA

1985-86     Instructor in Medicine, Cancer Research Institute, UCSF  Instructor, Department of Laboratory Medicine, UCSF

1986-89     Assistant Professor, Department of Laboratory Medicine, UCSF Assistant Professor, Department of Medicine, UCSF

1989-91     Associate Director, Division of Immunotherapy and Plasmapheresis  Unit,  Children’s Hospital of San Francisco, CA

1991-93     Associate Director, Division of Immunotherapy and Plasmapheresis Unit, California Pacific Medical Center, San Francisco, CA

1993-95    Associate Medical Director, HemaCare Corporation, San Francisco, CA

1995-97    Associate Medical Director, The Barron Centers, San Francisco, CA

1997-Present   Medical Director, Union Square Medical Associates, San Francisco, CA

2006-2016       Consulting Physician, Alan E. Beer Center for Reproductive Immunology & Genetics, Los Gatos, CA

2016-Present    Medical Director, Alan E. Beer Medical Center for Reproductive Immunology, Los Gatos, CA

 

Honors and Awards

1967  Cum Laude Society, Horace Mann Chapter

1968-71 Dean’s List, Columbia College

1972-75  Medical Honors, University of Lausanne Medical School

1975-78 Honors in Medicine, Neurology, and Psychiatry, Columbia University College of Physicians and Surgeons

1982-84 NIH Research Grant #HL-07100-08 454965-31779, Cancer Research Institute, University of California, San Francisco, CA

1984-85 Individual NRSA #1F32 HL-06871-01 CLN, National Heart, Lung and Blood Institute

1985-86 Research Fellowship, 85-N27A, American Heart Association, California Affiliate

1986-87 Research Fellowship, 86-N37A, American Heart Association, California Affiliate

1986-87 Academic Senate Research Grant, University of California, San Francisco, CA

1986-89 AIDS Clinical Research Grant, University of California, San Francisco, CA

1987-89 NIH RO1 AI/HL 24288, National Heart, Lung and Blood                                     Institute/National Institute of Allergy and Infectious Diseases

1987-89 AIDS Investigator Award K87SF057, California State Task Force on AIDS

1989-92 Children’s Hospital of San Francisco Grant 89-023

1990-93 Children’s Hospital of San Francisco Grant 90-041

1991-93 California Pacific Medical Center Grant 91-030

1989-94 Elizabeth Reed Taylor Foundation Grant

1994-96 DATA Research Grant

1999-2002 American Medical Association Physician’s Recognition Award

2001  San Francisco Magazine “500 Best Doctors” Award

2003-2006 American Medical Association Physician’s Recognition Award

2007-2010 American Medical Association Physician’s Recognition Award

2008  Outstanding Reviewer Award, Annals of Internal Medicine

2008-Present Annual Patients’ Choice Physician Award

2014-2019Lindorf Family Foundation Grant

2020-Present  Called2Serve Foundation Grant Organizations and Licenses

1979 Diplomate, National Board of Medical Examiners

1981 Diplomate, American Board of Internal Medicine

1978-81 New York State Medical License #138648

1981-Present California State Medical License #G44866

1978-Present Member, Southern Medical Association

1983-88 Associate, American Medical Association

1987-Present  Member, American Association for the Advancement of Science

1987-Present  Member, American Federation for Clinical Research

1988-Present Member, American Society of Hematology

1990-Present  Member, American Society For Apheresis (ASFA)

1990-Present  Member, Community Consortium of San Francisco

1990-Present  Member, International AIDS Society

1991-Present  Member, Clinical Immunology Society

1992-Present  Member, New York Academy of Sciences

1995-Present  Member, San Francisco Medical Society

1995-Present  Member, California Medical Association

1995-Present  Member, European Haematology Association

1995-Present  Member, California Blood Bank Society

1997-Present Member, International Council on Infertility Information Dissemination (INCIID)

2000 Diplomate, National Baromedical Services Training Program, Columbia, SC

2000-Present  Board Member, Lyme Disease Resource Center, Ukiah, CA

2000-Present  Board Member, International Lyme and Associated Diseases Society (ILADS) Organizations and Licenses

1979 Diplomate, National Board of Medical Examiners

1981 Diplomate, American Board of Internal Medicine

1978-81 New York State Medical License #138648

1981-Present  California State Medical License #G44866

1978-Present  Member, Southern Medical Association

1983-88  Associate, American Medical Association

1987-Present  Member, American Association for the Advancement of Science

1987-Present  Member, American Federation for Clinical Research

1988-Present  Member, American Society of Hematology

1990-Present  Member, American Society For Apheresis (ASFA)

1990-Present  Member, Community Consortium of San Francisco

1990-Present  Member, International AIDS Society

1991-Present  Member, Clinical Immunology Society

1992-Present  Member, New York Academy of Sciences

1995-Present  Member, San Francisco Medical Society

1995-Present  Member, California Medical Association

1995-Present  Member, European Haematology Association

1995-Present  Member, California Blood Bank Society

1997-Present  Member, International Council on Infertility Information Dissemination (INCIID)

2000  Diplomate, National Baromedical Services Training Program, Columbia, SC

2000-Present  Board Member, Lyme Disease Resource Center, Ukiah, CA

2000-Present  Board Member, International Lyme and Associated Diseases Society (ILADS)

 

Organizations and Licenses

1979                            Diplomate, National Board of Medical Examiners

1981                            Diplomate, American Board of Internal Medicine

1978-81                       New York State Medical License #138648

1981-Present               California State Medical License #G44866

1978-Present               Member, Southern Medical Association

1983-88                       Associate, American Medical Association

1987-Present               Member, American Association for the Advancement of Science

1987-Present               Member, American Federation for Medical Research

1988-Present               Member, American Society of Hematology

1990-2010                   Member, American Society For Apheresis (ASFA)

1990-2001                   Member, Community Consortium of San Francisco

1990-Present               Member, International AIDS Society

1991-Present               Member, Clinical Immunology Society

1992-2005                   Member, New York Academy of Sciences

1995-Present               Member, San Francisco Medical Society

1995-Present               Member, California Medical Association

1995-2001                   Member, European Haematology Association

1995-2001                   Member, California Blood Bank Society

1997-2004                   Member, International Council on Infertility Information Dissemination (INCIID)

2000                            Diplomate, National Baromedical Services Training Program,

Columbia, SC

2000-2011                   Board Member, California Lyme Disease Association (CALDA)

2011-Present               Board Member, LymeDisease.org (formerly CALDA)

2000-2016                   Board Member, International Lyme and Associated Diseases Society (ILADS)

2003-05                       President-Elect, ILADS

2005-2007                                      President, ILADS

2011-2014                   Vice President, ILADS

2014-Present               Past President, ILADS

2009-2011                   Medical Director, CALDA

2011-Present               Medical Director, LymeDisease.org (formerly CALDA)

2015-2016                   Overseas Fellow, Royal Society of Medicine

2017-2021                   Member, Society of General Internal Medicine

2019-Present               Member, American College of Physicians

2020-Present               Member, American Society for Reproductive Immunology

 

 Professional and Teaching Experience

1974-75                       Anatomy Dissection Instructor, University of Lausanne Medical School

1978-81                       Visiting Clinical Fellow, Columbia University College of Physicians and Surgeons

1982-89                       Hematology Course Instructor, Introduction to Clinical Medicine, UCSF School of Medicine

1985-88                       Attending Physician, Cancer Research Institute, UCSF

1985-89                       Attending Physician, Hematology Service, San Francisco General Hospital

1985-89                       Attending Physician, Laboratory Medicine Hematology Service, UCSF

1989-91                       Attending Physician, Hematology/Internal Medicine, Children’s Hospital of San Francisco

1990-91                       Advisor, California Blue Shield Medical Policy Committee on Quality and Technology

1990-91                       Editor-at-Large, Marcel Dekker Medical Publications

1991-Present               Attending Physician, Hematology/Internal Medicine, California Pacific Medical Center, San Francisco

1992-96                       Medical Advisor, Grupo de Apoio a Prevencao a AIDS (GAPA), Brazil

1993-96                       Medical Director, International DNCB Study Group, San Francisco

1995-96                       Scientific Advisory Committee, Co-factors Study Group, Paris, France

1996-2019                   Attending Physician, St. Francis Memorial Hospital, San Francisco

1996-Present               Attending Physician, Chinese Hospital, San Francisco

1999-2010                   Attending Physician, St. Mary’s Medical Center, San Francisco

1999-2012                   Attending Physician, Seton Medical Center, Daly City, CA

1999                            Program Project Reviewer, National Institute of Diabetes, Digestive & Kidney Diseases, Bethesda, MD

2000-2001                   Attending Physician, Hyperbaric Medicine Service, St. Francis Hospital, San Francisco

2000-Present               Member, California Lyme Disease Advisory Committee

2006-Present               Expert Medical Reviewer, Medical Board of California

2006-2013                   Member, QMedRx Advisory Panel

2007-Present               Member, Editorial Board, Expert Review of Anti-Infective Therapy

2010                            Member, Special Emphasis Panel CK10-004, “Assessment of Post-Treatment Lyme Disease Syndrome”. Centers for Disease Control & Prevention, Atlanta, GA.

2011-Present               Member, Editorial Board, BMJ Case Reports

2014-2018                   Member, Editorial Board, Chronic Diseases-International

2016                            International Reviewer, Lyme Disease Research Program, Dutch Ministry of Health, Welfare and Sport, The Hague, Netherlands.

2017-Present               Editor-in-Chief, American Journal of Infectious Diseases

2018-2019                   Guest editor, special edition of Healthcare(Basel): Lyme Disease: The Role of Big Data, Companion Diagnostics and Precision Medicine.

2018-Present               Editorial Board Member, Healthcare(Basel).

2018                            Invited reviewer, Czech Science Foundation, Prague, Czech Republic.

2018                            Invited thesis reviewer, Mt. Allison University Department of Biology, Sackville, New Brunswick, Canada.

2019-2020                   Guest editor, special edition of Healthcare (Basel): Lyme Disease and Related Tickborne Infections.

2021-Present               Guest editor, special edition of Diagnostics (Basel): Lyme Disease: Companion Diagnostics and Precision Medicine.

 

 Research Experience

1970-71                       Senior College Research Project:  Pica in Rats.  Department of Physiological Psychology, Columbia College, Dr. S. Woods.

1971-72                       Clinical Research in Endocrinology. Columbia-Presbyterian Medical Center, New York, NY, Dr. R. Vande Wiele.

1974-75                       Neurobiological Research on Rat Sensory Receptors.  University of Lausanne Medical School, Dr. H. Van der Loos.

1979-80                       Clinical Research on Circulating Immune Complexes.  St. Lukes-Roosevelt Hospital Center, Dr. W. Clark.

1982-85                       NIH Grants # HL-07100-08 454965-31779 and 1F32 HL-06871-01 CLN:  Study of Autoantibody in Immune Thrombocytopenic Purpura by a Monoclonal Technique.  Cancer Research Institute, University of California San Francisco, Dr. M.Shuman.

1985-87                       Research Fellowships 85-N27 and 86-37A.  American Heart Association, California Affiliate:  Characterization of Platelet Antibodies. Cancer Research Institute and Department of Laboratory Medicine, University of California San Francisco, Drs. M. Shuman & L. Corash.

1986-87                       AIDS Clinical Research Center Grant:  Chloroquine Treatment of AIDS-Related Immune Thrombocytopenic Purpura (ITP), Drs. D. Abrams & L. Corash

1987-89                       NIH RO1 #AI/HL 24288, National Heart, Lung and Blood Institute/National Institute of Allergy and Infectious Diseases:  Pathogenesis of AIDS-Related Immune Thrombocytopenic Purpura.

1987-89                       AIDS Investigator Award K87SF057, California State Task Force on AIDS:  Autoimmunity and AIDS.

1987-89                       Research Award R87SFO89, California State Task Force on AIDS:  Autoimmunity and AIDS.

1988-89                       AIDS Clinical Research Center Grant:  Monthly Intravenous Gammaglobulin Treatment of AIDS-Related Immune Thrombocytopenia.  Drs. D. Abrams, M. Jacobson & T. Chew.

1989-92                       Children’s Hospital of San Francisco Grant 89-023: Pathogenesis of HIV-Associated Peripheral Neuropathy.  Drs. D. Kiprov, D. Bredesen.

1990-93                       Children’s Hospital of San Francisco Grant 90-041: The Clinical Significance of LEU 17 T-Cells in HIV Disease.  Drs. D. Kiprov, J. Giorgi.

1991-93                       California Pacific Medical Center Grant 91-030: Comparison of Intravenous Gammaglobulin vs. Allogeneic Lymphocyte Immunization in Women with Recurrent Spontaneous Abortions – A Double Blind Crossover Study.  Drs. D. Kiprov, R. Nachtigall, C. Levinson.

1989-94                       Elizabeth Reed Taylor Foundation Grant: Peripheral Blood Lymphocyte Subset and Epidermal Langerhans Cell Evaluation in AIDS/ARC during DNCB Application.  Drs. W. Epstein, T. Berger.

1993-95                       Co-investigator, Passive Hyperimmune Therapy Program.  Dr. J. Levy, HemaCare Corporation.

1993-96                       Consultant, Swedish DNCB Study Group.  Drs. S. Britton, L. Morfeldt, K. Liebman.

1994-96                       Co-investigator, DNCB Topical Delivery System Development Project.  Drs. W. Epstein, L.B. Mills, Y.S. Zhu.

1994-96                       DATA Research Grant:  Quantitation of Viral Load in HIV-Infected Patients Treated with DNCB.  Drs. Y.S. Zhu, W. Epstein, L.B. Mills.

1996-99                                              IND Co-investigator:  Evaluation of Topical Dinitrochlorobenzene Therapy in Humans.  Queens Medical Center, Honolulu, HI.  Drs. L.B. Mills, R.I. Frankel, W.L. Epstein.

2008-2012                   Scientific Advisory Panel: Multimethod Examination of Diverse Manifestations of Lyme Disease. Department of Psychiatry, Stanford University. Cheryl Koopman, PhD.

2014-2019                   Co-investigator, Lindorf Family Foundation Grant: Characterization of Samples from Patients with Tickborne Diseases and Morgellons Disease. Marianne J. Middelveen, Jennie Burke, Eva Sapi, Peter J. Mayne, Hilary A. Schlinger.

2020-Present               Co-investigator, Called2Serve Foundation Grant: Characterization of Samples from Patients with Tickborne Diseases and Morgellons Disease. Marianne J. Middelveen, Eva Sapi, Melissa C. Fesler.

 

Professional Activity:

Invited Lectures, International

Research Seminar, Pasteur Institute, Paris, France

Research Seminar, Karolinska Institute, Stockholm, Sweden

Plenary Session, IV International Conference on HIV/AIDS in Cuba, Central America and the Carribbean, Havana, Cuba

International Conference on Tick Borne Diseases, York, United Kingdom

Deutsche Borreliose Gesellschaft Annual Meeting, Tabarz, Germany

Lyme Borreliosis Symposium, Aarhus, Denmark

ILADS Lyme Disease Conference, London, United Kingdom

ILADS Lyme Disease Conference, Augsburg, Germany

Norvect Lyme Disease Conference, Oslo, Norway

International Lyme Conference, Hermosillo, Mexico

 National

Hematology Rounds, Albert Einstein Medical Center, New York, NY

Research Seminar, American Red Cross Headquarters, Washington, DC

Hematology/Coagulation Rounds, Mt. Sinai Medical Center, New York, NY

Hematology Rounds, Memorial-Sloan Kettering Cancer Center, New York, NY

Hematology Grand Rounds, University of California, Los Angeles, CA

HemaCare Stem Cell Symposium, Los Angeles, CA

AIDS Seminar, National Institute of Allergy & Infectious Diseases, Bethesda, MD

DNCB Symposium, Broward Educational AIDS Conference on Health (BEACH ‘94), Ft. Lauderdale, FL

Allied Health Seminar, ASFA National Meeting, San Diego, CA

ILADS Clinical Conference, Princeton, NJ

ILADS Annual Meeting, Basking Ridge, NJ

Lyme Disease Association Annual Meeting, Philadelphia, PA

ILADS Annual Meeting, Philadelphia, PA

ILADS Annual Meeting, Rye, NY

ILADS Annual Meeting, Philadelphia, PA

Lyme Disease Association Annual Meeting, Boston, MA

ILADS Annual Meeting, Boston, MA

Charles E. Holman Foundation Morgellons Conference, Austin, TX

ILADS Annual Meeting, San Francisco, CA

ILADS Annual Meeting, Washington, DC

ACAM Symposium on Lyme Disease, San Diego, CA

ILADS Annual Meeting, Jersey City, NJ

ILADS Annual Meeting, Toronto, Canada

ILADS Annual Meeting, Boston, MA

ILADS Annual Meeting, San Diego, CA

ILADS Annual Meeting, Washington, DC

ILADS Annual Meeting, Ft. Lauderdale, FL

ILADS Annual Meeting, Philadelphia, PA

ASM Microbe Meeting, San Francisco, CA

ASRI Meeting, Santa Fe, NM

 Regional

Laboratory Medicine Grand Rounds, UCSF

Cancer Research Institute Grand Rounds, UCSF

UCSF-Stanford Combined Hematology Conference, UCSF

Hematology Rounds, Stanford University Medical Center, Palo Alto, CA

Medical Grand Rounds, St. Mary’s Hospital, San Francisco, CA

Nephrology Grand Rounds, UCSF

Medical Grand Rounds, Pacific Presbyterian Medical Center, San Francisco, CA

Medical Grand Rounds, Mt. Zion Hospital, San Francisco, CA

Hematopathology Rounds, Pacific Presbyterian Medical Center, San Francisco, CA

Plasmapheresis Conference, California Pacific Medical Center, San Francisco, CA

Annual Conference on Apheresis, California Blood Bank Society, Oakland, CA

Medical Grand Rounds, California Pacific Medical Center, San Francisco, CA

Medical Grand Rounds, Kaiser-Permanente Medical Center, San Francisco, CA

Research Seminar, Alza Corporation, Palo Alto, CA

AIDS Research Conference, Ralph K. Davies Medical Center, San Francisco, CA

Medical Grand Rounds, St. Francis Hospital, San Francisco, CA

AIDS Symposium, American Association for the Advancement of Science/Pacific Division, San Francisco, CA

Medical Grand Rounds, Brookside Hospital, San Pablo, CA

DNCB Symposium, HIV/AIDS and Chinese Medicine Conference, San Francisco, CA

Plasmapheresis Update, CBBS Regional Meeting, San Francisco, CA

AIDS Course Lecture, Mt. Tamalpais High School, Mill Valley, CA

OBGYN Grand Rounds, California Pacific Medical Center, San Francisco, CA

IVIG Seminar, California Blood Bank Society Annual Meeting, Irvine, CA

OBGYN Grand Rounds, Marin General Hospital, Greenbrae, CA

OBGYN Grand Rounds, Mills-Peninsula Hospital, Millbrae, CA

OBGYN Grand Rounds, Alta Bates Medical Center, Berkeley, CA

Tickborne Disease Seminar, Sierra Nevada Memorial Hospital, Grass Valley, CA

Lyme Disease Seminar, California Pacific Medical Center, San Francisco, CA

Seminar on Lyme Disease in California and the Wildlife Profession, Sacramento, CA

Medical Grand Rounds, Mendocino Coast Hospital, Ft. Bragg, CA

LDRC Conference on Lyme Disease, Ukiah, CA

OHM Conference on Lyme Disease, San Francisco, CA

California Nurse Practitioner Annual Meeting, Monterey, CA

University of California Lyme Symposium, Berkeley, CA

Ratna Ling Lyme Symposium, Cazadero, CA

CALDA Lyme Symposium, San Ramon, CA

Sonoma State University Lyme Symposium, Rohnert Park, CA

CALDA Lyme Symposium, Santa Rosa, CA

Medical Grand Rounds, Sutter Auburn Faith Hospital, Auburn, CA

Dermatology Symposium, University of California, San Francisco, CA

Amen Clinic Conference, Brisbane, CA

Glaxo SmithKline Symposium on Lyme Disease, Collegeville, PA

LDo Lyme Symposium, San Ramon, CA

Mayo Clinic Update on Infectious Diseases, Napa, CA

 

 Invited Reviewer

Acta Neurologica Scandinavica

Advances in Medical Sciences

AIDS

Allergologia et Immunopathologia

American Journal of Reproductive Immunology

Annals of Internal Medicine

Antibiotics

Biology

Blood

BMCID

BMJ

BMJOpen

Chronic Diseases-International

Clinical & Applied Immunology Reviews

Clinical Case Reports

Clinical Immunology

Clinical Infectious Diseases

Clinics

Drug Design, Development and Therapy

Epidemiology Open Access

European Journal of Haematology

European Journal of Neurology

Expert Opinion on Pharmacotherapy

Expert Review of Anti-Infective Therapy

Expert Review of Molecular Diagnostics

F1000 Prime

Fertility & Sterility

Folia Biologica

Future Microbiology

Future Neurology

Future Rheumatology

Gynecological Endocrinology

Heart & Lung

Immunity, Inflammation and Disease

Immunological Investigations

Indian Journal of Medical Research

Infectious Diseases and Therapy

International Journal of Environmental Research & Public Health

International Journal of Family Medicine

International Journal of General Medicine

International Medical Case Reports Journal

JAMA

Journal of Acquired Immunodeficiency Syndromes

Journal of Antimicrobial Chemotherapy

Journal of Clinical Apheresis

Journal of Clinical Investigation

Journal of Immunological Methods

Journal of Immunology

Journal of Infectious Diseases

Journal of Patient Experience

JSM Tropical  Medicine and Research

Lancet

Lancet Infectious Diseases

Lancet Neurology

Microorganisms

Milbank Quarterly

Molecular Neurobiology

Muscle and Nerve

Nature Reviews Disease Primers

Netherlands Organisation for Health Research and Development

Neuropsychiatric Disease and Treatment

New England Journal of Medicine

New York State Medical Journal

Obstetrics and Gynecology

Ophthalmic Plastic and Reconstructive Surgery

Pathogens

Pathogens and Global Health

PLoS ONE

Quarterly Review of Biology

Reproductive Biology and Endocrinology

Scientific Reports

Southern Medical Journal

Swiss National Research Foundation

Tourism Management

Vox Sanguinis

 

Scientific and Professional Meetings:

International

1986                            International Conference on AIDS, Paris, France (Poster)

1988                            International Conference on AIDS, Stockholm, Sweeden (Poster)

1988                            International Conference on Retroviruses and Disease, Heraklion, Crete (Poster)

1989                            International Conference on AIDS, Montreal, Canada (Paper)

1989                            International Conference on Neurological Complications of HIV

Infection, Quebec City, Canada (Paper)

1990                            International Conference on Management Issues in HIV Disease, Munich, Germany (Paper)

1990                            International  Conference  on the  Uses of  Intravenous Gammaglobulin, Interlaken, Switzerland (Paper)

1990                            International Conference on AIDS, San Francisco, CA (Poster)

1991                            International Conference on AIDS, Florence, Italy (Posters)

1992                            International Conference on AIDS, Amsterdam, Holland

(Poster)

1993                            International Conference on AIDS, Berlin, Germany (Poster)

1994                            International Conference on AIDS, Yokohama, Japan (Poster)

1995                            International Symposium on Clinical Immunology, San Francisco, CA (Paper)

1995                            Third International Conference on AIDS in Asia and the Pacific,

Chiang Mai, Thailand (Paper)

1996                            International Conference on AIDS, Vancouver, Canada (Poster)

1997                            International Symposium on Clinical Immunology, Amsterdam, Holland (Poster)

1997                            International Society of Hematology Meeting, Stockholm, Sweden (Poster)

1998                            12th World AIDS Conference, Geneva, Switzerland (Symposium)

1998                            International Conference on the Discovery and Clinical Development of Antiretroviral Therapies (ICDCD), St. Thomas, V.I. (Poster)

1999                            International Conference on HIV, Leukemia and Cancer, Marrakech, Morocco (Poster)

1999                            International Society of Hematology Meeting, Barcelona, Spain (Poster)

2000                            Second International Conference on Experimental and Clinical Reproductive Immunobiology, Amsterdam, Holland (Poster)

2004                            International Conference on Tick Borne Diseases, York, United Kingdom (Symposium)

2004                            IUIS/FOCIS Meeting, Montreal, Canada (Paper)

2004                            World Ehrlich Conference on Antimicrobial Therapy, Nurenberg, Germany (Symposium)

2007                                                        Deutsche Borreliose Gesellschaft Annual Meeting, Tabarz, Germany (Symposium)

2010                            Lyme Borreliosis Symposium, Aarhus, Denmark (Debate)

2010                            ILADS Lyme Disease Conference, London, United Kingdom (Symposium)

2011                            ILADS Lyme Disease Conference, Augsburg, Germany (Symposium)

2014                            ILADS Lyme Disease Conference, Augsburg, Germany (Symposium)

2015                            Norvect Lyme Disease Conference, Oslo, Norway (Symposium)

2019                            International Lyme Conference, Hermosillo, Mexico (Symposium)

 

National

1981-2001                   American Society of Hematology Annual Meeting (Papers, Posters)

1983-95                       American Federation for Clinical Research Annual Meeting (Papers)

1990-96                       American Society for Apheresis Annual Meeting (Papers)

1997-2000                   AAAI/AAI/CIS Joint Meeting (Posters)

2001                            First Annual FOCIS Meeting, Boston, MA (Poster)

2001                            American Society for Reproductive Immunology Annual Meeting, Chicago, Il (Poster)

2002                            Second Annual FOCIS Meeting, San Francisco, CA (Poster)

2002                            Second Annual ILADS Meeting, Somerset, NJ (Paper)

2003                            Columbia/LDA Conference on Tickborne Diseases, Philadelphia, PA (Paper)

2003                            Third Annual ILADS Meeting, Philadelphia, PA (Paper)

2004                            Fourth Annual ILADS Meeting, Rye, NY (Paper)

2005                            ASRI Annual Meeting, Providence, RI (Symposium)

2005                            Fifth Annual ILADS Meeting, Philadelphia, PA (Paper)

2006                            IDSA Annual Meeting, Toronto, Canada (Debate)

2006                            Sixth Annual ILADS Meeting, Philadelphia, PA (Paper)

2007                            Columbia/LDA Conference on Tickborne Diseases, Boston, MA (Debate)

2007                            Seventh Annual ILADS Meeting, Boston, MA (Paper)

2008                            Eighth Annual ILADS Meeting, San Francisco, CA (Symposium)

2009                            Charles E. Holman Foundation Morgellons Conference, Austin, TX (Paper)

2009                            Ninth Annual ILADS Meeting, Washington, DC (Paper)

2010                            Charles E. Holman Foundation Morgellons Conference, Austin, TX (Paper)

2010                            Tenth Annual ILADS Meeting, Jersey City, NJ (Symposium)

2011                            Eleventh Annual ILADS Meeting, Toronto, Canada (Paper)

2012                            Twelfth Annual ILADS Meeting, Boston, MA (Paper)

2013                            Thirteenth Annual ILADS Meeting, San Diego, CA (Symposium)

2014                            Fourteenth Annual ILADS Meeting, Washington, DC (Symposium)

2015                            Fifteenth Annual ILADS Meeting, Ft. Lauderdale, FL (Symposium)

2015                            Columbia/LDA Conference on Tickborne Diseases, Providence, RI (Debate)

2015                            American Association for the Advancement of Science (AAAS) Program, “Lyme Science & Solutions”, Washington, DC (Symposium)

2016                            Charles E. Holman Morgellons Disease Foundation Conference, Austin, TX (Paper)

2016                            Sixteenth Annual ILADS Meeting, Philadelphia, PA (Symposium)

2017                            Charles E. Holman Morgellons Disease Foundation Conference, Austin, TX (Paper)

2017                            Mayo Clinic Infectious Diseases Update, Napa, CA (Debate)

2019                            ASM Microbe Meeting, San Francisco, CA (Poster)

2021                            ASRI Meeting, Santa Fe, NM (Paper)

 

Regional

1985, 1988                  University of California Task Force on AIDS Research Symposium,

San Diego, CA (Papers)

1987                            California Heart Association Young Investigator Symposium, Santa

Barbara, CA (Paper)

2017, 2018                  MyLymeData Conference, San Ramon, CA (Symposium)

2003-2014                   Western Regional Meeting, American Federation for Medical Research, Carmel, CA (Papers)

2019-2020                   Western Medical Research Conference, American Federation for Medical Research, Carmel, CA (Posters)

University Service:

School of Medicine, UCSF

1982-89                       Introduction to Clinical Medicine – Advisory Panel

1988                            Qualifying Examination Reviewer, Department of Anatomy

1988-89                       Course Co-director, Laboratory Medicine 150:01 (Medical Student Elective)

 Department of Laboratory Medicine, UCSF

1986-89                       Ad Hoc Faculty Committee on Merits and Promotions

 Department of Medicine, UCSF

1987-89                       Ad Hoc Faculty Committee on Merits and Promotions

 Cancer Research Institute, UCSF

1987-88                       Library Committee

Medical Society Service:

1993-94                       Membership Committee, ASFA

1994-96                       Co-Chairman, Membership Committee, ASFA

1995-96                       Member, CBBS Apheresis Committee

1998                            Member, CBBS Scientific Advisory Committee

 

Public Testimony

 Stricker RB. Lyme Disease: Issues in Diagnosis and Reporting. Informational Hearing of the California Senate Committee on Health and Human Services, Sacramento, CA, February 25, 2004. Available at:

http://shea.senate.ca.gov/20032004legislativesummary

Stricker RB. Problems with Diagnosis and Treatment of Lyme Disease. IDSA Lyme Guidelines Review Panel Hearing, Washington, DC, July 30, 2009. Available at:

https://www.youtube.com/watch?v=BSxLfkoY8Po

Stricker RB. Lyme Disease: The Hidden Epidemic. Testimony before House Committee on Foreign Affairs, United States Congress, Washington, DC, July 17, 2012. Available at: http://archives.republicans.foreignaffairs.house.gov/hearings/view/?1455.

 

 Medicolegal Consulting

Bronson, Bronson & McKinnon, PA, Santa Rosa, CA

Haggard & Parks, PA, Coral Gables, FL

Hinshaw, Winkler, Draa, Marsh & Still, PA, San Jose, CA

Gentry, Phillips & Hodak, PA, Jacksonville, FL

Law Offices of David A. Levy, Burlingame, CA

Brann & Light, PC, Lewisburg, PA

Law Offices of Gerald I. Sugarman, Arroyo Grande, CA

Law Offices of Sheldon Rosenfield, Encino, CA

Ronald R. Huff, Attorney at Law, Sherman, TX

Law Offices of Moseley Collins III, El Dorado Hills, CA

Langenkamp & Curtis, LLP, Sacramento, CA

Thomson, Rhodes & Cowie, PC, Pittsburgh, PA

The Koks Firm, Woodlands, TX

Shaffer, Lombardo & Shurin, PC, Kansas City, MO

Ronemus & Vilensky, LLP, New York, NY

Law Office of Barbara Arnold, Oakland, CA

Schuering, Zimmerman & Doyle, LLP, Sacramento, CA

California Injury Agency LLP, Brentwood, CA

Carroll, Kelly, Trotter, Franzen, McBride & Peabody, Long Beach, CA

Law Office of Mark J. Zanobini, Mill Valley, CA

 

 

Publications:

1.         Stricker RB, Linker CA.  Pernicious anemia, 18q deletion syndrome, and IgA deficiency.  JAMA 1982;248:1359-1360.

2.         Volberding P, Conant MA, Stricker RB, Lewis BJ.  Chemotherapy in advanced Kaposi’s sarcoma:  Implications for current cases in homosexual men.  Am J Med 1983;74:652-656.

3.         Stricker RB, Linker CA.  Acute lymphoblastic leukemia with monosomy 7 in a Hiroshima survivor 37 years after the bomb.  JAMA 1983;250:640-641.

4.         Kay J, Stricker RB.  Hematologic and immunologic abnormalities in anorexia nervosa.  South Med J 1983;76:1008-1011.

5.         Stricker RB, Shuman MA.  Aplastic anemia complicating systemic lupus erythematosus:  Response to androgens in two patients.  Am J Hematol 1984;17:193-201.

6.         Peterson SP, Schiller N, Stricker RB.  Failure of two-dimensional echocardiography to detect Aspergillus endocarditis.  Chest 1984;85:291-294.

7.         Stricker RB, Wong D, Saks SR, Corash L, Shuman MA.  Acquired Bernard-Soulier syndrome.  J Clin Invest 1985;76:1274-1278.

8.         Stricker RB, Abrams DI, Corash L, Shuman MA.  Target platelet antigen in homosexual men with immune thrombocytopenia.  N Engl J Med 1985;313:1375-1380.

9.         Stricker RB, Linker CA, Crowley TJ, Embury SH.  Hematologic malignancy in sickle cell disease:  Report of four cases and review of the literature.  Am J Hematol 1986;21:223-230.

10.       Stricker, RB, Shuman MA.  Quinidine purpura:  Evidence that glycoprotein V is a target platelet antigen.  Blood 1986;67:1377-1381

11.       Stricker, RB, Wong D, Shiu D, Reyes PT, Shuman MA.  Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets:  Effects on surface proteins and platelet aggregation.  Blood 1986;40:515-524.

12.       Morrow WJW, Wharton MM, Stricker RB, Levy JA.  Analysis of immune complexes in the sera of patients with AIDS.  Clin Immunol Immunopathol 1986;40:515-524.

13.       Stricker RB, Reyes PT. Corash L, Shuman MA.  Evidence that a 210,000-dalton protein (GP 210) serves as a platelet F(c) receptor.  J Clin Invest 1987;79:1589-1594.

14.       Stricker RB, Lewis BH, Corash L, Shuman MA.  Post-transfusion purpura associated with a platelet autoantibody.  Blood 1987;69:1458-1463.

15.       Stricker RB, McHugh TM, Moody DJ, Morrow WJW, Stites DP, Shuman MA, Levy JA.  An AIDS-related autoantibody reacts with a specific antigen on stimulated CD4+T-cells.  Nature 1987;327:710-713.

16.       Valone FH, Stricker RB, Zamora PO, Shah VO, Mann PL.  Technitium-99m labeled 50 H.19 antibody fragments:  Interaction of the antibody with platelets.  Nuclear Medicine Biol 1988;15:439-450.

17.       Stricker RB, Lane PK, Leffert JD, Rodgers GM, Shuman MA, Corash L.  Development of anti-thrombin antibodies following surgery in patients with prosthetic cardiac valves.  Blood 1988;72:1375-1380.

18.       McHugh TM, Stites DP, Busch MP, Krowka JF, Stricker, RB, Hollander H.  Relationship of circulating levels of HIV antigen, anti-P24 antibody and HIV-containing immune complexes in patients infected with HIV.  J Infect Dis 1988;158:1088-1091.

19.       Fultz PN, Stricker RB, McClure HM, Anderson DC, Switzer WM, Horaist C.  Humoral response to SIV/SMM infection in macaque and mangabey monkeys.  J Acquired Immun Defic Syndrome 1990;3:319-329.

20.       Fultz PN, Siegel RS, Brodie A, Mawie AC, Stricker RB, Swenson RB, Anderson DC, McClure HM.  Prolonged CD4+ lymphocytopenia and thrombocytopenia in a chimpanzee persistently infected with HIV-1.  J Infect Dis 1991;163:441-447.

21.       Morrow WJW, Isenberg DA, Sobol RE, Stricker RB, Kieber-Emmons T.  AIDS virus infection and autoimmunity.  Clin Immunol Immunopathol 1991;58:163-180.

22.       Stricker, RB, Elswood BF, Abrams DI.  Dendritic cells and dinitrochlorobenzene (DNCB):  A new treatment approach to AIDS.  Immunol Letters 1991;29:191-196.

23.       Stricker RB, Main EK, Kronfield J, Kallas GS, Gerson LB, Autry AM, Kiprov DD. Severe post-partum eclampsia: Response to plasma exchange.  J Clin Apheresis 1992;7:1-3.

24.       Lalwani RB, Stricker, RB.  Successful use of antifibrinolytic therapy in acquired factor VIII deficiency.  Am J Med Sci 1992;303:398-401.

25.       Stroncek DF, Kline WE, Clay ME, Plachta L, Stricker RB, Hollander H, Greenspan J, Skubitz K.  Antibodies to granulocytes in patients infected with HIV.  J Lab Clin Med 1992;119:724-731.

26.       Stricker RB, Davis JA, Gershow J, Yamamoto K, Kiprov DD.  Thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus:  Report of a case and review of the literature from the plasmapheresis era.  J Rheumatol 1992;19:1469-1473.

27.       Stricker RB, Sanders KA, Owen WF, Kiprov DD, Miller RG.  Mononeuritis multiplex associated with cryoglobulinemia in HIV infection.  Neurology 1992;42:2103-2105.

28.       Stricker RB, Miller RG, Kiprov DD.  Role of plasmapheresis in acute disseminated (postinfectious) encephalomyelitis.  J Clin Apheresis 1992;7:173-179.

29.       Stricker RB, Zhu YS, Elwood BF, Dumlao C, Van Elk J, Berger TG, Tappero J, Epstein WL, Kiprov DD.  Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection.  Immunol Letters 1993;36:1-6.

30.       Stricker RB, Kwiatkowska BJ, Habis JA, Kiprov DD.  Myasthenic crisis: Response to plasmapheresis following failure of intravenous gammaglobulin.  Arch Neurol 1993;50:837-840.

31.       Elswood BF, Stricker RB.  Polio vaccines and the origin of AIDS. Medical Hypotheses 1994;42:347-354.

32.       Stricker RB, Barlogie B, Kiprov DD. Acquired factor VIII inhibitor associated with chronic alpha-interferon therapy.  J Rheumatol 1994;21:350-352.

33.       Andrews BT, Stricker RB, Kitt D, Galanakis DK, Gerson LB, Hieshima G.  Treatment of an intracranial arteriovenous malformation in a patient with complicated hemophilia:  Report of a case.  Am J Med Sci 1994;308:106-109.

34.       Stricker RB, Elswood BF, Goldberg B, Dumlao C, Van Elk J, Henry J, Winger EE, Epstein WL.  Clinical and immunologic evaluation of HIV-infected patients treated with dinitrochlorobenzene (DNCB).  J Am Acad Dermatol 1994;31:462-466.

35.       Stricker RB, Zhu YS, Elswood BF.  Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in plasma: Clinical correlates.  Res Virol 1995;146:151-158.

36.       Stricker RB, Goldberg B, Mills LB, Epstein WL.  Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene (DNCB).  J Am Acad Dermatol 1995;33:608-611.

37.       Stricker RB, Goldberg B.  Increase in lymphocyte subsets following treatment of HIV-associated neutropenia with granulocyte colony-stimulating factor.  Clin Immunol Immunopathol 1996;79:194-196.

38.       Goldberg B, Stricker RB.  HIV protease and the pathogenesis of AIDS.  Res Virol 1996;147:375-379.

39.       Stricker RB, Goldberg B.  The Maginot line and AIDS vaccines.  Medical Hypotheses  1997;48:527-529.

40.       Stricker RB, Goldberg B, Mills LB, Epstein WL.  Decrease in viral load associated with topical dinitrochlorobenzene (DNCB) therapy of HIV disease.  Res Virol 1997;148:343-348.

41.       Traub A, Margulis SB, Stricker RB.  Topical immune modulation with dinitrochlorobenzene (DNCB) in HIV disease:  A controlled trial from Brazil.  Dermatology 1997;195:363-367.

42.       Stricker RB, Goldberg B.  Weight gain associated with protease inhibitor therapy in HIV disease.  Res Virol 1998;149:123-126.

43.       Goldberg B, Stricker RB.  Apoptosis and HIV disease:  T-cells fiddle while the immune system burns.  Immunol Letters 1999;70:5-8.

44.       Stricker RB, Steinleitner A, Bookoff CN, Weckstein LN, Winger EE.  Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin (IVIG).  Fertil Steril 2000;73:536-540.

45.       Goldberg B, Stricker RB.  Bridging the gap:  Human diploid cell strains and the origin of AIDS.  J Theoretical Biol 2000;204:497-503.

46.       Goldberg B, Urnovitz HB, Stricker RB.  Beyond danger:  Unmethylated CpG dinucleotides and the immunopathogenesis of disease.  Immunol Letters 2000;73:13-18.

47.       Stricker RB, Winger EE.  Decreased CD57 lymphocyte subset in patients with chronic Lyme disease.  Immunol Letters 2001;76:43-48.

48.       Stricker RB, Burrascano JJ, Winger EE.  Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease.  Ann Agric Environ Med 2002;9:1-3.

49.       Stricker RB, Winger EE.  Musical hallucinations and Lyme disease.  South Med J 2003;96:711-715.

50.       Stricker RB, Lautin A.  The Lyme Wars: Time to listen.  Expert Opin Investig Drugs 2003;12:1609-1614.

51.       ILADS Working Group.  Evidence-based guidelines for the diagnosis and treatment of Lyme disease.  Expert Rev Anti-Infect Ther 2004;2:S1-S13.

52.       Johnson L, Stricker RB.  Treatment of Lyme disease:  A medicolegal assessment. Expert Rev Anti-Infect Ther 2004;2:533-57.

53.       Stricker RB, Lautin A, Burrascano JJ.  Lyme disease:  Point/Counterpoint. Expert Rev Anti-Infect Ther 2005;3:155-65.

54.       Stricker RB, Winger EE.  Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin.  Am J Reprod Immunol 2005;54:390-6.

55.       Clark DA, Coulam CB, Stricker RB.  Is intravenous immunoglobulin (IVIG) efficacious in early pregnancy failure?  A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF).  J Assist Reprod Genet 2006;23:1-13.

56.       Stricker RB, Lautin A, Burrascano JJ.  Lyme disease:  The quest for magic bullets. Chemotherapy 2006;52:53-9.

57.       Savely VR, Leitao MM, Stricker RB.  The mystery of Morgellons disease:  Infection or delusion?  Am J Clin Dermatol 2006;7:1-5

58.       Stricker RB. Counterpoint: Long-term antibiotic therapy improves persistent symptoms associated with Lyme disease. Clin Infect Dis 2007;45:149-157.

59.       Stricker RB, Johnson L.  Lyme disease: A turning point. Expert Rev Anti-Infect Ther 2007;5:759-62.

60.       Savely VR, Stricker RB. Morgellons disease: The mystery unfolds. Expert Rev Dermatol 2007;2:585-91.

61.       Stricker RB, Johnson L. Rapid Response: The American Academy of Neurology Lyme guidelines:  Through the looking glass. South Med J 2008;101:672.

62.       Stricker RB, Johnson L. Chronic Lyme disease and the ‘Axis of Evil’. Future Microbiol 2008;3:621-4.

63.       Stricker RB, Savely VR, Motanya NC, Giclas PC. Complement split products C3a and C4a in chronic Lyme disease. Scand J Immunol 2009;69:64-9.

64.       Johnson L, Stricker RB. Attorney General forces Infectious Diseases Society of America to redo Lyme guidelines due to flawed development process. J Med Ethics 2009;35:283-8.

65.       Stricker RB, Green CL, Savely VR, Chamallas SN, Johnson L. Safety of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease. Minerva Med 2010;101:1-7.

66.       Savely VR, Stricker RB. Morgellons disease: analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology. Clin Cosmetic Invest Dermatol 2010;3:67-78.

67.       Johnson L, Stricker RB. The Infectious Diseases Society of America Lyme guidelines:

A cautionary tale about development of clinical practice guidelines. Philos Ethics Humanit Med 2010;5:9.

68.       Stricker RB, Johnson L. Lyme disease diagnosis and treatment: Lessons from the AIDS epidemic. Minerva Med 2010;101:419-25.

69.       Stricker RB, Johnson L. Lyme disease: The next decade.  Infect Drug Resist 2011;4:1–9.

70.       Sapi E, Kaur N, Anyanwu S, Luecke DF, Datar A, Patel S, Stricker RB. Evaluation of in vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi. Infect Drug Resist 2011;4:97-113.

71.       Johnson L, Aylward A, Stricker RB. Health care access and burden of care for

patients with Lyme disease: A large United States survey. Health Policy  2011;102:64-71.

72.       Stricker RB, Green CL, Savely VR, Chamallas SN, Johnson L. Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease. Int J Gen Med 2011;4:639-46.

73.       Hynote ED, Mervine P, Stricker RB. Clinical evidence for rapid transmission of Lyme disease following a tickbite. Diagn Microbiol Infect Dis 2012;72:188-92.

74.       Middelveen MJ, Stricker RB. Filament formation associated with spirochetal infection: a comparative approach to Morgellons disease. Clin Cosmet Investig Dermatol 2011;4:167-77.

75.       Middelveen MJ, Rasmussen EH, Stricker RB. Morgellons disease: A chemical and light microscopic study.  J Clin Exp Dermatol Res 2012; 3:1-8.

76.       Stricker RB, Johnson L. Spirochetal ‘debris’ versus persistent infection in chronic Lyme disease: From semantics to science. Future Microbiol  2012;7:1243-6.

77.       Middelveen MJ, Mayne PJ, Kahn DG, Stricker RB. Characterization and evolution of dermal filaments from patients with Morgellons disease. Clin Cosmet Investig Dermatol 2013;6:1-21.

78.       Middelveen MJ, Burugu D, Akhila P, Burke J, Mayne PJ, Sapi E, Kahn DG, Stricker RB. Association of Borrelia burgdorferi infection with Morgellons disease F1000 Research 2013;2:25.

79.       Stricker RB, Johnson L. Persistent infection in chronic Lyme disease: Does form matter? Res J Infect Dis 2013;1:2.

80.       Mayne P, English JS, Kilbane EJ, Burke JM, Middelveen MJ, Stricker RB. Morgellons: a novel dermatological perspective as the multisystem infective disease borreliosis. F1000Research 2013;2:118.

81.       Stricker RB, Johnson L. Lyme disease: Call for a “Manhattan Project” to combat the epidemic. PLoS Pathogens 2014;10(1):e1003796.

82.       Johnson L, Wilcox S, Mankoff J, Stricker RB. Severity of chronic Lyme disease compared to other chronic conditions: A quality of life survey. PeerJ 2014;2:e322.

83.       Middelveen MJ, McClain SA, Bandoski C, Israel JR, Burke J, MacDonald A, Timmaraju A, Sapi E, Wang Y, Franco A, Mayne PJ, Stricker RB. Case report: Granulomatous hepatitis associated with chronic Borrelia burgdorferi infection. Research Open Access 2014;1:875.

84.       Middelveen MJ, Burke J, Sapi E, Bandoski C, Filush KR, Wang Y, Franco A, Timmaraju A, Schlinger H, Mayne PJ, Stricker RB. Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions. F1000Research 2015;3:309.

85.       Middelveen MJ, Bandoski C, Burke J, Sapi E, Filush KR, Wang Y, Franco A, Mayne PJ, Stricker RB. Exploring the association between Morgellons disease and Lyme disease:Identification of Borrelia burgdorferi in Morgellons disease patients. BMC Dermatol 2015;15:1.

86.       Stricker RB, Middelveen MJ. Sexual transmission of Lyme disease: Challenging the tickborne disease paradigm. Expert Rev Anti-infect Ther 2015;13:1303-1306.

87.       Stricker RB, Johnson L. Lyme disease: The promise of Big Data, companion diagnostics and precision medicine. Infect Drug Resist 2016;9:215–219

88.       Middelveen MJ, Stricker RB. Morgellons disease: A filamentous Borrelial dermatitis. Int J Gen Med 2016;9:349-354.

89.       Middelveen MJ, Rotaru GM, Filush KR, Sapi E, Burke J, Franco A, Malquori L, McElroy MC, Stricker RB. Canine filamentous dermatitis associated with Borrelia infection. J Vet Sci Med Diagn 2016;5:6.

90.       Middelveen MJ, Fesler MC, Stricker RB. History of Morgellons disease: From delusion to definition. Clin Cosmet Investig Dermatol 2018;11:71–90.

91.       Middelveen MJ, Sapi E, Burke J, Filush KR, Franco A, Fesler MC, Stricker RB. Persistent Borrelia infection in patients with ongoing symptoms of Lyme disease. Healthcare (Basel) 2018;6:33.

92.       Fesler MC, Middelveen MJ, Stricker RB. Clinical evaluation of Morgellons disease in a cohort of North American patients. Dermatol Reports 2018;10:7660.

93.       Stricker RB, Fesler MC. Chronic Lyme disease: A working case definition. Am J Infect Dis 2018; 14:1-44.

94.       Stricker RB, Middelveen MJ. Better drugs for Lyme disease: Focus on the spirochete. Infect Drug Resist 2018;11:1-3.

95.       Middelveen MJ, Shah JS, Fesler MC, Stricker RB. Relapsing fever Borrelia in California: A pilot serological study. Int J Gen Med 2018;11:373–382.

96.       Middelveen MJ, Du Cruz I, Fesler MC, Stricker RB, Shah JS. Detection of tickborne infection in Morgellons disease patients by serological and molecular techniques. Clin Cosmet Investig Dermatol 2018;11:561–9.

97.       Fesler MC, Middelveen MJ, Burke J, Stricker RB. Erosive vulvovaginitis associated with Borrelia burgdorferi infection. J Invest Med High Impact Case Rep 2019;7:1.

98.       Middelveen MJ, Filush KR, Bandoski C, Kasliwala RS, Melillo A, Stricker RB, Sapi E. Mixed Borrelia burgdorferi and Helicobacter pylori biofilms in Morgellons disease dermatological specimens. Healthcare (Basel) 2019;7:70.

99.       Shah JS, Liu S, Cruz ID, Poruri A, Maynard R, Shkilna M, Korda M, Klishch I, Zaporozhan S, Shtokailo K, Andreychyn M, Stricker RB, Ramasamy R. Line immunoblot assay for tick-borne relapsing fever and findings in patient sera from Australia, Ukraine and the USA. Healthcare (Basel) 2019;7:121.

100.     Middelveen MJ, Martinez RM, Fesler MC, Sapi E, Burke J, Shah JS, Nicolaus C, Stricker RB. Classification and staging of Morgellons disease: Lessons from syphilis. Clin Cosmet Investig Dermatol 2020; 13:145–164.

101.     Fesler MC, Shah JS, Middelveen MJ, Burrascano JJ, Stricker RB. Lyme disease: diversity of Borrelia species in California and Mexico based on a novel immunoblot assay. Healthcare (Basel) 2020;8:97-113. https://doi.10.3390/healthcare8020097

102.     Stricker RB, Fesler MC. A novel plan to deal with SARS‐CoV‐2 and COVID‐19 disease. J Med Virol. 2020; 92:1394–1395. https://doi.org/10.1002/jmv.25945

103.     Middelveen MJ, Stricker RB. Plant fiber contaminants in Morgellons disease skin samples. SKIN The Journal of Cutaneous Medicine. 2020; 4:484-485.

104.     Stricker RB, Fesler MC. Flattening the risk: Pre-exposure prophylaxis for COVID‐19. Infect Drug Resist 2020;13:3689–3694. http://doi.org/10.2147/IDR.S264831

105.     Johnson L, Shapiro M, Stricker RB, Vendrow J, Haddock J, Needell D. Antibiotic treatment response in chronic Lyme disease: Why do some patients improve while others do not? Healthcare (Basel) 2020;8:383-405. https://doi.10.3390/healthcare8040383

106.     Fesler MC, Stricker RB. Pre-exposure prophylaxis for COVID-19 in pregnant women. Int J Gen Med. 2021;14:279-284. https://doi.10.2147/IJGM.S295627

107.     Middelveen MJ, Hagbladd JS, Lewis J, Robichaud GA, Martinez RM, Shah JS, Du Cruz I, Fesler MC, Stricker RB. Dermatological and genital manifestations of Lyme disease including Morgellons disease. Clin Cosmet Investig Dermatol 2021 (in press)

 

 Abstracts and Letters

1.         Stricker RB, Pompilio JK, Axelrod JL, Kochman RS, Newton JC. Neisseria subflava endophthalmitis.  Am J Ophthal 1982;94:423-424.  (Letter).

2.         Stricker RB, Linker CA.  Pernicious anemia, 18q deletion syndrome, and IgA deficiency.  JAMA 1983;249:2327-2328. (Letter).

3.         Stricker RB, Abrams DI, Corash L, Shuman MA.  Target platelet antigen in AIDS-related immune thrombocytopenia.  Blood 1984;64(Suppl): 241a (Abstract).

4.         Stricker RB, Abrams DI, Corash L, Shuman M.  Target platelet antigen in homosexual men with immune thrombocytopenia.  Clin Res 1985;33:551A (Abstract).

5.         Abrams D, Kiprov D, Stricker R, Volberding P.  Prednisone therapy in AIDS-related immune thrombocytopenia (ITP):  Clinical, hematologic and immunologic consequences.  Proc Am Soc Clin Oncol 1985; 4: 3 (Abstract).

6.         Morrow WJW, Wharton MM, Stricker RB, Levy JA.  Analysis of immune complexes in the sera of patients with AIDS.  Seventh European Immunology Meeting, Jerusalem 1985 (Abstract).

7.         Stricker RB, Shuman MA.  Quinidine purpura:  Evidence that the target platelet antigen is glycoprotein  V.  Blood 1985;66 (Suppl):299a (Abstract).

8.         Stricker RB, Lewis BH, Corash L, Shuman MA.  Post-transfusion purpura associated with alloantibodies against PLA1 and glycoprotein IIb and a platelet autoantibody.  Blood 1985;66 (Suppl):298a (Abstract).

9.         Stricker RB, Wong D, Shiu D. Lysenko P, Shuman MA.  Activation of plasminogen on the surface of human platelets by tissue plasminogen activator.  Blood 1985;66 (Suppl):344a (Abstract).

10.       Stricker RB, Shuman MA.  Evidence that an Mr 210,000 glycopretein (GP 210) is a platelet F(c) receptor.  Clin Res 1986;34:664a (Abstract).

11.       Stricker RB, Wharton MM, Morrow WJW, Levy JA, Shuman MA.  Detection of HLA antigen in serum using polyethylene glycol:  Evidence of altered HLA expression in AIDS.  Clin Res 1987;35:141A (Abstract).

12.       Stricker RB, Embury SH.  Hematologic malignancy in sickle cell disease.  Am J Hematol 1987; 24: 112 (Letter).

13.       Stricker RB, Venook AP, Reyes PT, Shuman MA.  Antiplatelet antibody in sepsis-associated thrombocytopenia.  Blood 1986;68 (Suppl):118a (Abstract)

14.       Stricker RB, Koerper MA, Bussel J, Shuman MA.  Target platelet antigens in Childhood immune thrombocytopenic purpura.  Blood 1986;68 (Suppl):118a (Abstract)

15.       Stricker RB, McHugh TM, Krowka JF, Stites DP, Shuman MA, Levy JA.  Patients with AIDS and AIDS-related conditions produce an autoantibody reactive with a specific antigen on stimulated helper/inducer T-cells.  Blood 1986;68 (Suppl):134a (Abstract).

16.       Damon L, Adams M, Stricker RB, Ries CA.  Intracranial bleeding during treatment with hydroxyethyl starch.  N Engl J Med 1987;317:965-965 (Letter).

17.       Stricker RB.  Immunosuppressant therapy in AIDS.  Lancet 1987;ii:796 (Letter).

18.       Stricker RB, McHugh TM, Marx PA, Morrow WJW, Levy JA, Shuman MA, Stites DP, Neyman PD.  Prevalence of an AIDS-related autoantibody against CD4+ T-cells in humans and monkeys.  Blood 1987:70 (Suppl):127a (Abstract).

19.       Stricker RB, McHugh TM, Levy JA, Shuman MA, Stites DP, Neyman PD.  Characterization of the autoantibody binding site on CD4+ T-cells in patients with acquired immunodeficiency syndrome (AIDS).  Blood 1987;70 (Suppl):127a (Abstract).

20.       Stricker RB, Corash L, Neyman PD.  Immunoblot detection of serum antibodies against platelet proteins in patients with immune thrombocytopenia.  Blood 1987;70 (Suppl):115a (Abstract).

21.       Stricker RB.  Sexual activity and urinary tract infections in women.  Ann Int Med 1988;108:773-774 (Letter)

22.       Stricker RB.  Association of hematologic malignancies with hemoglobinopathies.  Am J Hematol 1988;28:131 (Letter).

23.       Stricker RB, Blackwood LL, McHugh TM, Stites DP, Neyman PD.  Autoantibody-mediated cytotoxicity directed against CD4+ T-cells in AIDS.  Blood 1988;72:360a.  (Abstract)

24.       Stricker RB, Grimaldi AG, Neyman PD.  Resemblance between a target platelet antigen and a human immunodeficiency virus precursor protein.  Blood 1988;72:360a.  (Abstract)

25.       Stricker RB, Bredesen DE, Neyman PD, Wesley MA, Mahawar SK.  Autoimmunity in the pathogenesis of HIV-related peripheral neuropathy.  V International Conference on AIDS, Montreal, Canada, 1989 (Abstract).

26.       Stricker RB, Fultz PN, Haislip AM.  Monkeys with simian AIDS produce an antibody directed against a histone-like protein on CD4+ T-cells.  V International Conference on AIDS, Montreal, Canada, 1989 (Abstract).

27.       Stricker RB, Corash L.  Antibodies to thrombin in postsurgical patients.  Blood 1989;73:1386 (Letter).

28.       Stricker RB, McDonagh AF, Skach WF, Haislip AM. Coagulopathy associated with pronounced hyperbilirubinemia.  Clin Res 1989;37:388A  (Abstract).

29.       Baker JR, Saunders NB, Polly SN, Landry F, Stricker RB, Burman KD.  Identification of thyroid histones as autoantigens using human monoclonal antibodies.  Clin Res 1989;37:588A (Abstract).

30.       Polly SN, Saunders NB, Murray K, Stricker RB, Burman KD, Baker JR.  Evaluation of the binding characteristics of human monoclonal antibodies directed against histones. Clin Res 1989;37:588A (Abstract).

31.       Stricker RB, Kwiatkowska B, Miller RG, Kiprov DD.  Combination plasmapheresis and intravenous gammaglobulin therapy in HIV-positive and HIV-negative patients.  J Clin Apheresis 1990;5:174 (Abstract)

32.       Kiprov D, Kwiatkowska B, Stricker R, Miller R.  Therapeutic apheresis and intravenous gammaglobulin therapy in HIV-related immune syndromes.  6th International Conference on AIDS, San Francisco, CA, 1990 (Abstract)

33.       Stroncek D, Kline W, Skubitz K, Sullivan C, Clay M, Plachta L, Stricker R, Greenspan J, Hollander H, McCullough J.  Anti-granulocyte antibodies detected in HIV infected patients.  Blood 1990;76 (Suppl) 495a (Abstract).

34.       Stricker RB, Miller RG, Kiprov DD.  Role of plasmapheresis in acute disseminated (postinfectious) encephalomyelitis.  J Clin Apheresis 1991;6:184 (Abstract).

35.       Stricker RB, Main EK, Kronfield J, Kallas GS, Gerson LB, Autry AM, Kiprov DD.  Severe post-partum eclampsia:  Response to plasma exchange.  J Clin Apheresis 1991;6:184 (Abstract).

36.       Stricker RB, Giorgi JV, Dumlao C, Kiprov DD.  Significance of CD8+CD38+ T-cells in HIV infection.  Seventh International Conference on AIDS, Florence, Italy, 1991 (Abstract).

37.       Stricker RB, Kiprov DD.  HIV-related immune thrombocytopenic purpura (ITP):  Relation to circulating immune complex levels and response to immune modulation.  Seventh International Conference on AIDS, Florence, Italy, 1991 (Abstract).

38.       Stricker RB, Elswood BF.  Origin of AIDS.  Lancet 1992; 339:867 (Letter).

39.       Stricker RB.  Thrombocytopenia as a clue to HIV.  Ann Int Med 1992;117:94 (Letter).

40.       Stricker RB, Kiprov DD.  Pathogenic considerations and prognostic factors in thrombotic thrombocytopenic purpura (TTP).  J Clin Apheresis 1992;7:40 (Abstract).

41.       Posner MR, Elboim HS, Tumber MB, Stricker RB.  Human monoclonal cell surface-reactive autoantibodies:  An initial characterization of reactivity and specificity.  SBT Proceedings 1992 (Abstract).

42.       Zhu YS, Stricker RB, Gong Y, Kiprov DD, Isaacs S, Cimino G.  Quantitation of HIV-1 RNA in plasma of asymptomatic, ARC and AIDS patients.  VIII International Conference on AIDS, Amsterdam, Holland, July 1992 (Abstract).

43.       Kiprov DD, Stricker RB, Miller RG.  Treatment of HIV neuropathy with plasmapheresis and intravenous gammaglobulin.  VIII International Conference on AIDS, Amsterdam, Holland, July 1992 (Abstract).

44.       Stricker RB, Zhu YS, Elswood BF, Dumlao C, Van Elk J, Berger TG, Tappero J, Epstein WL, Kiprov DD.  Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection.  VIII International Conference on AIDS, Amsterdam, Holland, July 1992 (Abstract).

45.       Kiprov D, Stricker R, Nachtigall R, Main E, Smith S, Dumlao C, Jacobson A, Garovoy M, Levinson C.  A controlled study of lymphocyte immunization in recurrent spontaneous abortion (RSA): The role of antilymphocyte antibodies (ALA).  Riv Immunol Immunofarm 1992;12:108 (Abstract).

46.       Kiprov D, Stricker R, Nachtigall R, Main E, Smith S, Dumlao C, Jacobson A, Garovoy M, Levinson C.  Intravenous gammaglobulin (IVIG) treatment of recurrent spontaneous abortion (RSA) associated with combined alloimmune and autoimmune abnormalities.  Riv Immunol Immunofarm 1992;12:108 (Abstract).

47.       Stricker RB, Elswood BF.  Topical dinitrochlorobenzene in HIV disease.  J Am Acad Dermatol 1993;28:796-797 (Letter).

48.       Stricker RB. CD8 T cells in human immunodeficiency virus infection. Arch Int Med 1993;153:779 (Letter).

49.       Stricker RB, Elswood BF. Immunosuppressive effect of zidovudine. Ann Intern Med 1993;118:571-572 (Letter).

50.       Stricker RB.  Autoantibody in post-transfusion purpura.  Vox Sang 1993;65:337-338 (Letter).

51.       Stricker RB, Elswood BF, Goldberg B, Dumlao C, Van Elk J, Berger TG, Epstein WL. Analysis of lymphocyte subsets in HIV-infected patients treated with dinitrochlorobenzene (DNCB).  IX International Conference on AIDS, Berlin, Germany, June 1993 (Abstract).

52.       Stricker RB, Kwiatkowska BJ, Habis JA, McLeod DE, Kiprov DD. Response to plasmapheresis following failure of intravenous gammaglobulin in patients with myasthenia gravis and Guillain-Barre syndrome.  J Clin Apheresis 1993;8:54 (Abstract).

53.       Stricker RB, Minor DR, Kiprov DD. Thrombotic microangiopathy complicating renal carcinoma: Report of the first two cases. J Clin Apheresis 1993;8:55 (Abstract).

54.       Elswood BF, Stricker RB.  Polio vaccines and the origin of AIDS.  Res Virol 1993;144:175-177 (Letter).

55.       Kiprov D, Stricker R, Nachtigall R, Main E, Smith S, Dumlao C, Jacobson A, Garovoy M, Levinson C.  Intravenous gammaglobulin (IVIG) treatment of recurrent spontaneous abortion (RSA) associated with combined alloimmune and autoimmune abnormalities.  J Immunol 1993;150:166A (Abstract).

56.       Stricker RB, Kiprov DD.  Mononeuritis and cryoglobulins.  Neurology 1993;43:2159 (Letter).

57.       Stricker RB, Elswood BF.  HIV contamination of poliovaccines.  Lancet 1994;343:52-53 (Letter).

58.       Stricker RB.  Antithyroid antibodies in recurrent pregnancy loss.  Am J Obstet Gynecol 1994;170:956 (Letter).

59.       Stricker RB.  Controversy over multiple chemical sensitivities.  Ann Intern Med 1994;120:249-251 (Letter).

60.       Stricker RB, Elswood BF.  Delayed-type hypersensitivity and AIDS.  Ann Intern Med 1994;120:343-344 (Letter).

61.       Stricker RB, Goldberg B.  Cellular immune response to HIV gp160 vaccine.  J Acquired Immun Defic Syndr 1994;7:989 (Letter).

62.       Stricker RB, Elswood BF, Goldberg B, Henry J, Winger EE, Epstein WL.  Clinical and immunologic monitoring of HIV-infected patients treated with topical dinitrochlorobenzene (DNCB).  Tenth International Conference on AIDS, Yokohama, Japan, August 1994 (Abstract).

63.       Stricker RB.  Persistently perplexing purpuras:  Thrombotic thrombocytopenic purpura and  immune thrombocytopenic purpura.  Ann Intern Med 1994;121:720-721 (Letter).

64.       Elswood BF, Stricker RB.  Polio vaccines and the origin of AIDS:  Clarification.  Medical Hypotheses 1995;44:226 (Letter).

65.       Stricker RB, Youvan TD, McGrath MF, Levy J.  Potential benefit of repeated plasma donation in asymptomatic HIV-infected individuals. J Clin Apheresis 1995;10:52 (Abstract).

66.       Stricker RB, Goldberg B.  Dinitrochlorobenzene and Chagasí disease. Lancet 1995;345:327 (Letter).

67.       Goldberg B, Stricker RB.  AIDS research policy.  Science 1995;267:1405-1407 (Letter).

68.       Stricker RB, Youvan TD, McGrath MF, Levy J.  Potential benefit of repeated plasma donation in asymptomatic HIV-infected individuals with decreased CD4 T-cell counts.  J Invest Med 1995;43:250A (Abstract).

69.       Stricker RB.  Neurologic manifestations of HIV infection. Ann Intern Med 1995;122:883-884 (Letter).

70.       Stricker RB, Goldberg B, Epstein WL.  Immunological alterations in  patient with systemic lupus erythematosus treated with topical dinitrochlorobenzene (DNCB).  Lancet 1995;345:1505-1506 (Letter).

71.       Stricker RB.  Tuberculous mastitis.  South Med J 1995;88:698 (Letter).

72.       Stricker RB.  Two enigmas in one patient:  TTP and SLE.  South Med J 1995;88:795 (Letter).

73.       Stricker RB.  What about plasma?  Arch Intern Med 1995;155:1817 (Letter).

74.       Stricker RB, Goldberg B.  Host-directed therapy for AIDS.  Ann Intern Med 1995;123:471-472 (Letter).

75.       Stricker RB, Goldberg B.  Safety of topical dinitrochlorobenzene.  Lancet 1995;346:1293 (Letter).

76.       Stricker RB, Goldberg B.  Increase in lymphocyte subsets following treatment of HIV-associated neutropenia with granulocyte colony-stimulating factor (G-CSF). Blood 1995;86(Suppl):560a (Abstract).

77.       Stricker RB, Goldberg B.  Zidovudine and psoriasis.  J Am Acad Dermatol 1996;34:152 (Letter).

78.       Stricker RB, Goldberg B.  Significance of cytokine patterns in alopecia areata before and after therapeutic allergic contact dermatitis.  J Invest Dermatol 1996;106:379-380 (Letter).

79.       Stricker RB, Gullett JH, Williams LE, Goldberg B.  Co-trimoxazole desensitization syndrome (CODS):  Delayed hematologic toxicity complicating prophylactic therapy in AIDS patients.  AIDS 1996;10:927-929 (Letter).

80.       Stricker RB, Goldberg B.  G-CSF and exacerbation of rheumatoid arthritis.  Am J Med 1996;100:665-666 (Letter).

81.       Stricker RB, Goldberg B, Epstein WL.  Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene.  J Am Acad Dermatol 1996;35:491-493 (Letter).

82.       Stricker RB, Goldberg B, Epstein WL.  Decrease in viral load associated with topical dinitrochlorobenzene (DNCB) therapy of HIV disease.  Eleventh International Conference on AIDS, Vancouver, BC, July 1996 (Abstract).

83.       Stricker RB.  Interferon alfa and autoimmunity.  South Med J 1996;89:645 (Letter).

84.       Stricker RB, Goldberg B, Epstein WL.  Combination antiretroviral therapy and topical immune modulation with dinitrochlorobenzene (DNCB) in HIV disease.  Blood 1996;88(Suppl):38b (Abstract).

85.       Stricker RB, Goldberg B.  Make peer review really anonymous.  J NIH Res 1996;8:14 (Letter).

86.       Stricker RB, Elswood BF.  Polio vaccines and the origin of AIDS:  An update.  Medical Hypotheses 1997;48:193 (Letter).

87.       Stricker RB, Goldberg B.  AIDS and pure red cell aplasia. Am J Hematol 1997;54:264 (Letter).

88.       Stricker RB, Goldberg B.  The Manchester seaman.  Lancet 1997;349:360 (Letter).

89.       Stricker RB, Goldberg B.  Time for change at journals.  J NIH Res 1997;9:14 (Letter).

90.       Stricker RB.  Interferon-( treatment and formation of factor VIII antibodies.  Ann Intern Med 1997;126:829-830 (Letter).

91.       Stricker RB, Man KM, Bouvier D, Goldberg DA, Mendiola AE.  Pancreatorenal syndrome associated with combination antiretroviral therapy in HIV disease.  Lancet 1997;349:1745-1746 (Letter).

92.       Stricker RB, Goldberg B.  Polio vaccines and retroviral contamination.  J Infect Dis 1997;176:545-546 (Letter).

93.       Stricker RB, Goldberg B.  CD8 T-cell response to antiretroviral therapy.  JAIDS 1997;15:176-177 (Letter).

94.       Stricker RB, Goldberg B.  Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.  Lancet 1997;350:588-590 (Letter).

95.       Stricker RB, Goldberg B, Winger EE, Epstein WL.  Clinical, immunologic and virologic effects of highly active antiretroviral therapy (HAART) combined with topical dinitrochlorobenzene (DNCB) in HIV disease.  12th  World AIDS Conference, Geneva, Switzerland, 1998 (Abstract).

96.       Stricker RB, Goldberg B.  Fat accumulation and HIV-1 protease inhibitors.  Lancet 1998;352:1392 (Letter).

97.       Stricker RB, Goldberg B.  Buffalo humps and antiretroviral therapy.  Ann Intern Med 1999;130:241-242 (Letter).

98.       Stricker RB, Goldberg B.  Lichen nitidus and dinitrochlorobenzene. J Am Acad Dermatol 1999;40:647-648 (Letter).

99.       Stricker RB, Goldberg B, Winger EE, Epstein WL.  Improved cellular immune function associated with topical dinitrochlorobenzene (DNCB) therapy in HIV disease.  Clin Immunol 1999;90:458 (Abstract).

100.     Stricker RB, Steinleitner A, Bookoff CN, Weckstein LN, Winger EE.  Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin (IVIG).  Clin Immunol 1999;90:474-475 (Abstract).

101.     Stricker RB, Goldberg DA, Hu C, Hsu JW, Goldberg B.  A syndrome resembling primary aldosteronism (Conn syndrome) in untreated HIV disease.  AIDS 1999;13:9-10 (Letter).

102.     Stricker RB, Goldberg B.  Oral thrush and HIV protease inhibitors.  JAIDS 1999;22:105-106 (Letter).

103.     Stricker RB, Goldberg B.  Time for peer review reform. The Scientist 2000;14:6 (Letter).

104.     Stricker RB, Winger EE.  Decreased CD57 lymphocyte subset in patients with chronic Lyme disease.  FASEB J 2000;14:A1058 (Abstract).

105.     Stricker RB, Goldberg B.  Hormonal effects of HIV protease inhibitors.  Ann Intern Med 2000;133:482-483 (Letter).

106.     Stricker RB, Thomas DG, Brooks JP.  Viagra and HAART.  South Med J 2000;93:1037 (Letter).

107.     Stricker RB, Winger EE.  Decreased CD57 lymphocyte subset in patients with chronic Lyme disease.  Blood 2000;96:45b (Abstract).

108.     Stricker RB, Steinleitner A, Bookoff CN, Winger EE.  Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin (IVIG).  J Reprod Immunol 2001;51:66 (Abstract).

109.     Stricker RB, Goldberg B.  Origin of AIDS.  Lancet 2001;357:73 (Letter).

110.     Stricker RB, Winger EE.  Holmes-Adie syndrome and Lyme disease.  Lancet  2001;357:805 (Letter).

111.     Stricker RB, Steinleitner A, Bookoff CN, Winger EE.  Update and critical analysis of low-dose intravenous immunoglobulin (IVIG) therapy for immunologic abortion.  Clin Immunol 2001;99:188-189 (Abstract).

112.     Goldberg B, Stricker RB.  Outcomes of a trial of HIV-1 Immunogen in patients with HIV infection.  JAMA 2001;285:2192 (Letter).

113.     Stricker RB, Steinleitner A, Bookoff CN, Winger EE.  Critical analysis of intravenous immunoglobulin (IVIG) therapy for recurrent spontaneous abortion.  Am J Reprod Immunol 2001;45:363-364 (Abstract).

114.     Stricker RB, Steinleitner A.  Intravenous immunoglobulin therapy for repeated failure of in-vitro fertilization.  Fertil Steril 2001;76:637-639. (Letter).

115.     Stricker RB, Winger EE.  Normalization of the CD57 natural killer cell subset associated wth prolonged antibiotic therapy in patients with chronic Lyme disease.  Clin Immunol 2002;103:S117 (Abstract).

116.     Stricker RB.  Lyme disease controversy:  Use and misuse of language.  Ann Intern Med 2002;137:775-777 (Letter).

117.     Stricker RB, Harris NS, Yong DC, Winger EE. Clinical and seroepidemiologic characteristics of Babesia WA-1 coinfection in patients with Lyme disease in California. J Invest Med 2003;51:S145 (Abstract).

118.     Stricker RB, Phillips SE. Lyme disease without erythema migrans: Cause for concern?  Am J Med 2003;115:72-73 (Letter).

119.     Stricker RB, Gaito A, Harris NS, Burrascano JJ.  Coinfection in patients with Lyme disease:  How big a risk?  Clin Infect Dis 2003;37:1277-1279 (Letter).

120.     Stricker RB, Goldberg B.  Carcinogenicity of statins.  South Med J 2003;96:837-838 (Letter).

121.     Stricker RB, Lautin A.  Lyme disease and optic neuritis:  Long-term follow-up of seropositive patients.  Neurology 2003;61:1162-3 (Letter).

122.     Stricker RB, Gaito A, Harris NS, Burrascano JJ.  Treatment of early Lyme disease:  Tales of the lost and wayward.  Ann Intern Med 2004;140:577-8 (Letter).

123.     Stricker RB, McNeil EL.  Duration of antibiotic therapy for Lyme disease:  The controversy continues. Ann Intern Med 2004;140:e316-7 (Letter).

124.     Stricker RB, Moore DH,Winger EE. Clinical  and  immunologic  evidence  for  transmission  of Lyme  disease  through  intimate  human  contact.  J Invest Med 2004;52:S151 (Abstract).

125.     Stricker RB, Winger EE.  Prognostic significance of very low CD57 natural killer cells in patients with chronic Lyme disease. Clin Invest Med 2004;27:108A (Abstract).

 126.     Stricker RB, Lautin A, Burrascano JJ.  State of the art:  Lyme disease and the legacy of Paul Ehrlich.   Proceedings of the World Ehrlich Conference on Antimicrobial Therapy, Nurenberg, Germany, 2004 (Abstract). http://www.ehrlich2004.org/index.html

127.     Stricker RB, Hall PD, Lautin A.  Appropriateness of Lyme disease testing:  An appropriate analysis? Ann Fam Med 2004 (Letter). Published electronically at http://www.annfammed.org/cgi/eletters/2/4/341#1049

 128.     Stricker RB, Thomas SL, Moore DH, Winger EE. Efficacy  of clarithromycin/cefdinir combination therapy in patients with chronic Lyme disease. J Invest Med 2005;53:S156  (Abstract).

129.     Stricker RB, Winger EE.  Intravenous immunoglobulin (IVIG) therapy for immunologic abortion.  Am J Reprod Immunol 2005;53:274 (Abstract).

130.     Stricker RB, Johnson LB, Harris N, Burrascano JJ. Inaccurate information about Lyme disease on the Internet. Ped Infect Dis J 2005;24:577-8 (Letter).

131.     Phillips SE, Harris NS, Horowitz R, Johnson L, Stricker RB.  Lyme disease: Scratching the surface.  Lancet  2005;366:1771 (Letter).

132.     Phillips SE, Burrascano JJ, Harris NS, Johnson L, Smith PV, Stricker RB.  Chronic infection in “post-Lyme borreliosis syndrome”.  Int J Epidemiol  2005;34:1439-40 (Letter).

133.     Phillips SE, Burrascano JJ, Harris NS, Horowitz R, Johnson L, Smith PV, Stricker RB.  Rash decisions about STARI and Lyme disease.  Clin Infect Dis 2006;42:306-7 (Letter).

134.     Phillips SE, Burrascano JJ, Horowitz R, Savely VR, Stricker RB. Lyme disease testing. Lancet Infect Dis 2006;6:122-3 (Letter).

135.     Phillips SE, Burrascano JJ, Harris NS, Horowitz R, Johnson L, Smith PV, Stricker RB.  Coinfection with Borrelia and Babesia:  Bad or Worse? J Infect Dis  2006;193:901-2. (Letter).

136.     Stricker RB, Brewer JH, Burrascano JJ, Horowitz R, Johnson L, Phillips SE, Savely VR, Sherr VT. Possible role of tick-borne infection in “cat-scratch disease”.  Arthritis Rheum 2006;54:2347-2348. (Letter).

137.     Stricker RB, Savely VR, Zaltsman A, Citovsky V.  Contribution of Agrobacterium to Morgellons disease.  J Invest Med 2007;55:S123 (Abstract).

138.     Winger EE, Reed JL, Stricker RB. Lymphocyte immunization therapy (LIT) combined with intravenous immunoglobulin (IVIG) improves live birth rates in women with primary recurrent spontaneous abortion (RSA) Am J Reprod Immunol 2007;58:203 (Abstract).

139.     Winger EE, Reed JL, Stricker RB. Treatment with tumor necrosis factor (TNF) inhibitors and intravenous immunoglobulin (IVIG) improves live birth rates in women with recurrent spontaneous abortion (RSA). Am J Reprod Immunol 2007;58:225 (Abstract).

140.     Stricker RB, Johnson LB. Let’s tackle the testing. BMJ 2007;335:1008 (Letter).

141.     Stricker RB, Green CL, Savely VR, Chamallas SN. Safety of intravenous antibiotic therapy in chronic Lyme disease. J Invest Med 2008;56:190 (Abstract).

142.     Stricker RB, Maloney EL. Acute infection with human monocytic Ehrlichiosis:

The tip of the iceberg? South Med J 2008;101;214-5 (Letter)

143.     Stricker RB, Johnson L. Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review). Neurology 2008;70:1719 (Letter).

144.     Stricker RB, Johnson L. Searching for autoimmunity in “antibiotic-refractory” Lyme arthritis. Mol Immunol 2008;45:3023-4 (Letter).

145.     Stricker RB, Corson AF, Johnson L. Reinfection in patients with Lyme disease: not enough evidence. Clin Infect Dis 2008;46:950 (Letter).

146.     Stricker RB, Johnson L. Persistent Borrelia burgdorferi infection following treatment with antibiotics and anti-tumor necrosis factor-alpha. J Infect Dis 2008;197:1352-3 (Letter).

147.     Stricker RB, Johnson L. Prolonged Lyme disease treatment: enough is enough. Neurology 2008;71:1380 (Letter).

148.     Stricker RB, Johnson L. Serologic tests for Lyme disease: More smoke and mirrors. Clin Infect Dis 2008;47:1111-2 (Letter).

149.     Stricker RB, Johnson L. The Infectious Diseases Society of America Lyme guidelines: poster child for guidelines reform. South Med J 2009;102:565-6 (Editorial).

150.     Stricker RB, Johnson L. Gender bias in chronic Lyme disease. J Womens Health (Larchmt) 2009;18:1717-8 (Letter).

151.     Stricker RB, Winger EE. Natural killer cells in chronic Lyme disease. Clin Vaccine Immunol 2009;16:1704 (Letter).

152.     Stricker RB, Johnson, L. IDSA Lyme Guidelines: Response to Dr. Gershon’s Letter. South Med J 2009;102:1089-90 (Letter).

153.     Savely VR, Stricker RB. Morgellons disease: analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology. J Invest Med 2010;58:214-5 (Abstract).

154.     Stricker RB, Johnson L. Anti-neural antibody reactivity in patients with post-treatment Lyme disease. Brain Behav Immun 2010;24:1025 (Letter)

155.     Stricker RB, Johnson L. Persistent symptoms following treatment of early Lyme disease:False hope? Am J Med 2010;123:e25. (Letter).

 156.     Stricker RB, Johnson L. Long-term outcomes of patients with early Lyme disease:More false hope? Clin Infect Dis 2010;50:1683-4 (Letter).

 157.     Koopman C, Holmes T, Stricker R, Cameron D, Green C, Lin Y, Castillo A, Aylward A, Whisnant J, Brodhead C. Demographic and medical factors associated with distinct symptom clusters of Lyme disease. Psychosom Med 2010;72:A-64 (Abstract).

158.     Johnson L, Stricker RB. Final report of the Lyme disease review panel of theInfectious Diseases Society of America: A Pyrrhic victory? Clin Infect Dis 2010;51:1108-9 (Letter).

159.     Stricker RB, Frismodt C, Schwarzbach A. Reply to a feature article defending Danish Borrelia diagnostics. Ugeskr Laeger 2010;172:2405.

160.     Stricker RB, Johnson L. Chronic Lyme disease: In defense of the patient enterprise. FASEB J 2010;24:4632-3 (Letter).

161.     Stricker RB, Johnson L. “Lyme literacy” and physicians in Connecticut. J Pediatr 2011;158:518-9 (Letter).

162.     Stricker RB, Johnson L. ‘Rare’ infections mimicking multiple sclerosis: Consider Lymedisease. Clin Neurol Neurosurg 2011;113:258–60 (Letter).

163.     Stricker RB, Johnson L. The pain of chronic Lyme disease: moving the discourse backward? FASEBJ 2011;25:4085-7 (Letter).

164.     Stricker RB, Johnson L. Antiphospholipid antibodies in patients with persistent Lyme disease symptoms. Lupus 2012;21:346-7 (Letter).

165.     Stricker RB, Hynote ED, Mervine P. Clinical evidence for rapid transmission of Lyme disease following a tickbite: Response to Piesman and Gray. Diagn Microbiol Infect Dis 2012;73:104-5 (Letter).

166.     Stricker RB, Johnson L. Risk of malignancy associated with Lyme disease: Still up in the air. Int J Cancer 2012;131:2717 (Letter).

167.     Stricker RB, Middelveen MJ. Morgellons disease: More questions than answers. Psychosomatics 2012;53:504-5 (Letter).

168.     Middelveen MJ, Akhila P, Mayne PJ, Sapi E, Kahn DG, Stricker RB. Association of Borrelia burgdorferi infection with Morgellons disease. J Invest Med 2013;61:225 (Abstract).

169.     Stricker RB, Johnson L. Outpatient parenteral antibiotic therapy for Lyme borreliosis: a ‘real world’ view. Q J Med 2013;106:201-3 (Letter).

170.     Stricker RB, Johnson L. Chronic Lyme disease: Liberation from Lyme denialism. Am J Med 2013;126:e13-14 (Letter).

171.     Stricker RB, Johnson L. Borrelia burgdorferi aggrecanase activity: More evidence forpersistent infection in Lyme disease. Front Cell Infect Microbiol 2013;3:00040 (Letter).

 172.     Stricker RB, Johnson L. Lyme disease vaccination: Safety first. Lancet Infect Dis2014;14:12 (Letter).

 173.     Middelveen MJ, Bandoski C, Burke J, Sapi E, Mayne PJ, Stricker RB. Isolation and detection of Borrelia burgdorferi from human vaginal and seminal secretions. J Investig Med 2014;62:280-1 (Abstract).

 174.     Stricker RB, Middelveen MJ. Association of Borrelia burgdorferi infection with Morgellons disease. Article comments. F1000 Research 2013;2:25. Available at: http://f1000research.com/articles/2-25/v1#article-comments

175.     Stricker RB, Middelveen MJ. Isolation and identification of Borrelia burgdorferi in human vaginal and seminal secretions. Article comments. F1000Research 2015;3:309. Available at: http://f1000research.com/articles/3-309/v2

176.     Stricker RB. Lyme disease: time for a new approach? BMJ 2015;351:h6520 (Letter).

177.     Stricker RB, Johnson L. Circular reasoning in CDC Lyme disease test review. PubPeer Comment on Moore et al. Emerg Infect Dis. 2016;22:1169–77. Available at: http://www.ncbi.nlm.nih.gov/pubmed/27314832.

178.     Stricker RB. Study conclusion is incorrect. PubPeer Comment on Berende et al. N Engl J Med 2016; 374:1209-20. Available at: https://www.ncbi.nlm.nih.gov/pubmed/27028911

179.     Stricker RB. Another LYMErix whitewash. PubPeer Comment on Aronowitz RA,  Milbank Q. 2012;90:250-77. Available at: https://www.ncbi.nlm.nih.gov/pubmed/22709388

180.     Stricker RB. An outdated view of Lyme neuroborreliosis. PubPeer Comment on Halperin JJ, Expert Rev Anti Infect Ther. 2018;16:5-11. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29278020

181.     Fesler MC, Middelveen MJ, Burke J, Stricker RB. Erosive vulvovaginitis associated with Borrelia burgdorferi infection. J Invest Med 2019;67:149 (Abstract).

182.     Middelveen MJ, Sapi E, Fesler MC, Stricker RB. Borrelia-associated dermopathy: Potential role of biofilms. ASM Microbe 2019, CPHM-953 (Poster).

183.     Fesler MC, Shah JS, Middelveen MJ, Burrascano JJ, Stricker RB. Lyme disease: diversity of Borrelia species in California and Mexico based on a novel immunoblot assay. J Invest Med 2020;68(Suppl 1):A85 (Abstract).

184.     Stricker RB. Christina’s World and the universe of Lyme disease. Am J Med 2021;134:e74 (Letter).

185.     Fesler MC, Sanow MC, Mantle DL, Trobough GE, Nasseri-Nik N, Stricker RB. Chronic histiocytic intervillositis: Successful treatment of recurrent miscarriage with anticoagulation and immunotherapy (Beer protocol). (Abstract, submitted).

186.     Fesler MC, Athar H. Chishti AH, Middelveen MJ, Stricker RB.Treatment of chronic Babesia duncani infection with an HIV protease inhibitor regimen. (Abstract, submitted).

 

 Review Articles / Book Chapters / Commentary 

1.         Mitsuyasu RT, Stricker RB, Gaynor R.  Hematologic abnormalities in AIDS.  Education Program, American Society of Hematology, 1988.  pp. 89-96.

2.         Stricker RB.  Pathogenesis and treatment of HIV-related immune thrombocytopenia.  In:  AIDS Clinical Review 1990.  Volberding P, Jacobson MA (eds.)  New York:  Marcel Dekker.  Chapter 6, pp. 95-114.

3.         Stricker RB, Kwiatkowska BJ, Miller RG, Kiprov DD. Plasmapheresis and intravenous gammaglobulin in the treatment of HIV-related autoimmune processes. In: AIDS und HIV-Infektionen. Jaeger H (ed),  Landsberg AL, 1990;VII:5.2, 1-10.

4.         Stricker RB, Kiprov DD.  Combined use of plasmapheresis and intravenous gammaglobulin in the treatment of HIV-positive and HIV-negative autoimmune syndromes.  In:  Immunotherapy with Intravenous Immunoglobulines, Imbach P. (ed). Academic Press 1991, pp. 345-359.

5.         Stricker RB.  Hemostatic abnormalities in HIV disease.  Hematol Oncol Clin North Am 1991;5:249-265.

6.         Stricker RB.  Hematologic aspects of HIV disease:  Diagnostic and therapeutic considerations.  J Clin Apheresis 1991;6:106-109.

7.         Kiprov DD, Miller RG, Stricker RB.  Treatment of HIV-associated neuropathy with plasmapheresis and intravenous gammaglobulin.  Therapeutic Plasmapheresis 1993;12:277-282.

8.         Epstein WL, Stricker RB.  Immunomodulation by allergic contact sensitization:  The DNCB story.  Am J Contact Dermatitis 1995;6:117-121.

9.         Stricker RB, Epstein WL.  Topical immune modulation (TIM):  A novelapproach to the immunotherapy of systemic disease.  Immunol Letters 1997;59:145-150.

10.       Stricker RB.  Antibiotic treatment of rheumatic diseases.  Lyme Times 2000;28:40-41.

11.       Stricker RB.  ILADS meeting focuses on progress and controversy.  Lyme Times 2001;30:45-48.

12.       Stricker RB.  Review:  Programmed cell death in animals and plants.  Quart Rev Biol 2001;76:491.

13.       Stricker RB.  The LDA meeting:  Waltzing with Tantalus.  Lyme Times 2002;32:60-62.

14.       Stricker RB, Steinleitner A, Winger EE.  Intravenous immunoglobulin (IVIG) therapy for immunologic abortion.  Clin Appl Immunol Rev 2002;2:187-199.

15.       Stricker RB. Lyme disease:  A potential polymicrobial infection. ASM News 2003;69:265.

16.       Phillips SE, Bransfield R, Sherr VT, Smith HA, Dickson K, Stricker RB.  Evaluation of antibiotic treatment in patients with persistent symptoms of Lyme disease:  An ILADS position paper.  www.ilads.org/position2.htm

 17.       Stricker RB.  Lyme disease as a potential polymicrobial infection.  ASM News 2004;70:1.

18.       Stricker RB, Goldberg B.  Slouching toward an AIDS vaccine.  ASM News 2004;70:347.

19.       Goldberg B, Stricker RB.  Origin of AIDS revisited.  ASM News 2005;71:157.

20.       Stricker RB.  Recognizing Lyme. New York Times, May 17, 2005. Available at: http://query.nytimes.com/gst/fullpage.html?res=9C04E5D61F30F934A25756C0A9639C8B63

21.       Phillips SE, Burrascano JJ, Harris NS, Horowitz R, Smith HA, Stricker RB.  Treatment available for  chronic Lyme.  Cape Cod Times, August 6, 2005

22.       Stricker RB, Johnson L.  Chronic Lyme disease: A persistent inflammatory infection.  Microbe 2006;1:51.

23.       Stricker RB. Medical revisionists threaten effective Lyme treatment. Hartford Courant, July 31, 2006. Available at: http://www.ilads.org/lyme_research/lyme_publications13.html

24.       Stricker RB.  Two standards of care for Lyme disease. Hospital News 2006;19(11):17.

25.       Stricker RB.  Risks of Lyme vaccine. Microbe 2007;2:321.

26.       Stricker RB. Lymerixâ risks revisited. Microbe 2008;3:1-2.

27.       Stricker RB. Book Review: Molecular Biology of Spirochetes. Future Microbiol 2008;3:133-134.

28.       Johnson L, Stricker R. Consumer acceptance depends on whether guidelines reflect patient values. Health Affairs blog, June 9, 2010. Available at:http://content.healthaffairs.org/content/29/7/1400/reply – healthaff_el_332215

29.       Stricker RB. CDC perpetuates myths about Lyme disease testing, treatment. Poughkeepsie Journal, June 30, 2013. Available at:http://www.vermontlyme.com/cdc-perpetuates-myths-about-lyme-disease-testing-treatment/

30.       Stricker RB. MyLymeData conference presentation, May 17, 2017. Available at: https://www.lymedisease.org/lymepolicywonk-stricker-mylymedata/

31.       Stricker RB. What does Lyme disease do to your body? Seeker video, April 26, 2019. Available at: https://www.lymedisease.org/sick-lyme-disease-video/

32.       Stricker RB. Dr. Stricker helps train doctors in Mexico to treat Lyme disease. LYRI conference, Hermosillo, Mexico June 5, 2019. Available at: https://www.lymedisease.org/stricker-lyme-mexico-lyri/